Xaliproden

Xaliproden is a medication used to treat Parkinson’s disease and other movement disorders. It works by increasing the amount of the neurotransmitter dopamine in the brain. It can improve muscle control, reduce tremor, and improve walking, speech, and balance. Xaliproden is available in tablet and oral suspension forms. Common side effects include nausea, constipation, dizziness, and insomnia.

Xaliproden is a drug currently under investigation for its potential to treat neurodegenerative diseases [1]. Here's a breakdown of what we know about it:

How it Works:

  • Xaliproden acts on serotonin receptors in the brain, specifically the 5-HT1A receptor [1]. This receptor is involved in various functions, including mood, cognition, and movement.
  • By interacting with this receptor, Xaliproden exhibits neurotrophic and neuroprotective effects. In simpler terms, it may help nerve cells grow and survive [2].

Potential Uses:

  • Xaliproden has been investigated as a treatment for several neurodegenerative diseases, including:
    • Amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig's disease [1, 3].
    • Alzheimer's disease [1].
    • Chemotherapy-induced peripheral neuropathy, a nerve damage side effect from some cancer treatments [2].

Current Status:

  • While early studies showed promise, Xaliproden hasn't been approved for any medical conditions yet [1, 3].
  • Larger clinical trials (studies in people) are needed to confirm its effectiveness and safety for specific uses [2].

Important to Know:

  • As Xaliproden is still under development, its long-term effects and potential side effects are not fully understood.
  • It's crucial to consult a doctor before using any investigational drugs like Xaliproden.
     
Anatomical Therapeutic Chemical Classification
N - Nervous system
N07 Other nervous system drugs
N07X - Other nervous system drugs
N07XX Other nervous system drugs
External Links